GEO推动广告投放升级，市场规模有望高速增长 GEO生成式引擎优化是面向生成式AI应用的广告投放技术，其通过广告内容投喂，使得广告内容被纳入AI信息库，进而提升广告内容在AI生成内容中 的被引用概率。从模式来看，用户直接向浏览器提问，不再点入网页，有望重塑营销版图。 | | | 12 1 1 1 2 1 2 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 | | | | --- | --- | --- | --- | --- | | | 1990年代 | 2000年代 | 2010年代 | 2020年代 | | 主要媒介 | 电子邮件 | 搜索引擎 | 社交媒体 | 社交媒体 | | 流量入口 | 电视机 | 门户网站 | 移动App | 原生AI应用 | | 主要广告 | 邮件广告 | 网站banner | 开屏广告 | 内容营销 | | 形式/技术 | 电视广告 | 竞价排名、SEO | 信息流广告 | GEO | 近期，GEO、AI医疗等概念持续发酵，其中GEO ...

软件ETF（515230）跟踪的是软件指数（H30202），该指数从市场中选取涉及软件开发、销售及相关服 务的企业证券作为指数样本，成分股以技术领先、创新能力强为特征。作为信息技术行业的代表性指 数，它集中反映了软件行业的整体表现和发展趋势。 风险提示：提及个股仅用于行业事件分析，不构成任何个股推荐或投资建议。指数等短期涨跌仅供参 考，不代表其未来表现，亦不构成对基金业绩的承诺或保证。观点可能随市场环境变化而调整，不构成 投资建议或承诺。提及基金风险收益特征各不相同，敬请投资者仔细阅读基金法律文件，充分了解产品 要素、风险等级及收益分配原则，选择与自身风险承受能力匹配的产品，谨慎投资。 相关机构表示，GEO概念持续发酵，有望驱动广告代理商商业模式变革，AI+营销有望重塑广告行业内 核。此外，AI医疗方面，ChatGPT推出health服务，可以提供实时并且准确的健康服务。AI会是持续的 科技主线，硬件切软件是迟早的，只是什么时候的问题。从产业链的闭环看，AI基建的大规模投入， 必须在软件端形成共振，才能保证长期投入的可持续性。当前北美AI大模型和国产AI大模型之间形成 了一定的性能差距，后续国产算力供给瓶颈缓 ...

Group 1: Commercial Aerospace Sector - The commercial aerospace concept is experiencing renewed activity, with stocks like Tongyu Communication achieving a three-day consecutive rise, and China Satellite hitting a historical high with a market cap of 137.9 billion yuan and a trading volume exceeding 7 billion yuan [3]. - On January 10, the International Telecommunication Union (ITU) reported that China submitted an application for an additional 203,000 satellites, covering 14 satellite constellations, indicating significant growth potential in the sector [5]. Group 2: Photovoltaic Sector - The photovoltaic sector is active, particularly in perovskite batteries and space photovoltaic applications, with companies like Dongfang Risheng and Maiwei Shares showing notable gains. Recent focus on space photovoltaic technology has been highlighted by several listed companies [5]. - Institutional research indicates that space computing has gained consensus, with overseas giants planning to establish space data centers, suggesting a potential explosive growth phase for commercial aerospace in the coming years [5]. Group 3: AI Medical Sector - The AI medical and pharmaceutical sectors are strengthening, with stocks like Dean Diagnostics and Meian Health achieving consecutive gains. The development of an AI-driven high-throughput drug virtual screening platform by Tsinghua University has been a significant milestone [6][9]. - The GEO (Generative AI Optimization) concept continues to show strength, with companies like Liou Shares and Inertia Media hitting the limit up. Many domestic listed companies are entering the GEO field through investments and product line expansions [9]. Group 4: AI Programming Sector - The AI programming concept saw fluctuations but ultimately rose, with stocks like Zhuoyi Information hitting the limit up. The announcement by Elon Musk regarding the upcoming upgrade of xAI's Grok Code, which will support complex programming tasks, has generated market interest [11].

Group 1: Market Performance - The Hang Seng Index rose by 0.86%, gaining 224 points to close at 26,456 points, while the Hang Seng Tech Index increased by 2.08% [1] - The early trading volume in the Hong Kong stock market reached HKD 168.4 billion [1] Group 2: AI and Technology Sector - Leading AI model companies saw significant gains, with MINIMAX-WP (00100) up over 31% and Zhiyun (02513) rising by 30% due to a strategic partnership with Didi [1] - Other AI-related stocks also performed well, including Mifengshi (02556) which rose by 18%, and AI pharmaceutical companies like Yingshi Intelligent (03696) up 12% and Yidu Tech (02158) up over 8% [1] - Kuaishou-W (01024) increased by 5.62%, with expectations of significant revenue growth in FY2026 due to its AI initiatives [1] - Kingdee International (00268) rose by 10.71%, benefiting from accelerated AI model integration in industrial processes [1] Group 3: Lithium Industry - Tianqi Lithium (09696) and Ganfeng Lithium (01772) saw increases of over 5% and 6% respectively, driven by export tax adjustments that may stimulate demand [1] Group 4: New Listings and Stock Movements - The new stock Hao Wei Group (00501) debuted with a 15% increase, recognized as a leading Fabless semiconductor design company [2] - LFG Investment Holdings (03938) resumed trading and surged over 120% following a cash offer from Chen Shaoyang at a significant discount [2] Group 5: Regulatory Impact on Companies - Contemporary Amperex Technology Co., Ltd. (Ningde Times) fell by 2.94% due to new battery export tax policies and rising lithium carbonate prices [3] - Smoore International (06969) declined by 1.87% as the export tax rebate for electronic cigarettes is set to be canceled, potentially impacting profits [4]

Core Viewpoint - The stock of Insilico Medicine (3696.HK) surged by 17% to a new high of HKD 55, marking a cumulative increase of over 52% since its listing, with a market capitalization exceeding HKD 30 billion, following a significant R&D collaboration announcement with Servier worth USD 888 million focused on oncology drug development [1] Group 1: Company Developments - Insilico Medicine announced a research collaboration with Servier totaling USD 888 million, aimed at identifying and developing new therapeutic drugs for challenging oncology targets [1] - The company has established numerous AI-driven drug development collaborations and pipeline licensing agreements in recent years [1] Group 2: Market Context - The rise in Insilico Medicine's stock price is attributed to multiple factors, including recent advancements in the AI healthcare sector and collaborations by other AI pharmaceutical companies, such as CrystalGenomics [1] - The AI medical industry is experiencing significant progress, with new catalysts emerging in areas like brain-computer interfaces and innovative drug development [1]

以上内容与数据，与有连云立场无关，不构成投资建议。据此操作，风险自担。 在跟踪恒生生物科技指数的ETF中，恒生医药ETF（159892）规模排名第一（超70亿），流动性良好， 为投资者布局恒生生物科技提供了便捷的ETF工具。 2026年初，港股医药板块迎来多重催化：AI医疗迎重磅BD交易，脑机接口海外利好频传，商保创新药 目录于1月1日正式实施。恒生生物科技指数强势上涨，年内涨幅一度突破13%，领涨港股市场关键指 数。 港交所于2025年11月推出恒生生物科技指数期货，进一步优化其不断拓展的衍生产品生态圈，为投资者 提供了精准的风险管理工具，恒生生物科技指数也成为港股医药、医疗板块唯一有指数期货的指数。 ...

Core Viewpoint - The Hong Kong stock market's healthcare sector is experiencing significant activity, particularly in brain-computer interfaces and AI healthcare, with notable gains in various stocks and the launch of a new healthcare ETF [1][3]. Group 1: Market Performance - The Hong Kong Stock Connect healthcare sector index has risen for seven consecutive days since the beginning of 2026, with a peak increase of over 1% on January 12 [1]. - Notable stock performances include: - Yimray Sunshine: +8.76% with a market cap of 3.3 billion - Aidi Kang Holdings: +6.81% with a market cap of 3.7 billion - MicroPort Scientific: +6.49% with a market cap of 27.7 billion - Alibaba Health: +2.77% with a market cap of 959 billion [1]. Group 2: ETF Launch and Characteristics - The newly launched Hong Kong Stock Connect Healthcare ETF (159137) aims to track the healthcare innovation index, covering key sectors such as CXO, AI healthcare, medical devices, and innovative drugs [3]. - The healthcare theme index has shown high elasticity and volatility, with a maximum increase of over 148% during the last healthcare bull market, significantly outperforming comparable indices [3][4]. Group 3: Recent Developments and Innovations - Recent advancements in brain-computer interfaces and AI healthcare have led to increased attention in the healthcare sector, with OpenAI launching ChatGPTHealth and Neuralink planning large-scale production of brain-computer interface devices by 2026 [4][5]. - Tsinghua University announced the development of an AI-driven high-throughput drug virtual screening platform, highlighting the growing intersection of AI and healthcare [5]. - The National Medical Products Administration in China is working on standards for medical devices using brain-computer interface technology, indicating a supportive regulatory environment [5]. Group 4: Investment Opportunities - The A-share market offers investment tools such as the largest healthcare ETF (512170), which includes 12 AI healthcare and brain-computer interface concept stocks, with a combined weight of over 36% [6]. - The current price-to-earnings ratio of the CSI Healthcare Index is 35.46, indicating a favorable valuation compared to historical averages [6].

Core Viewpoint - The Hong Kong stock market's healthcare sector is experiencing significant activity, particularly in brain-computer interfaces and AI healthcare, with notable gains in various stocks and the launch of a new healthcare ETF [1][3]. Group 1: Market Performance - The Hong Kong Stock Connect healthcare sector index has seen a continuous rise, gaining over 1% and marking seven consecutive days of increases since the beginning of 2026 [1]. - Notable stock performances include: - Yimray Sunshine: 8.76% increase, current price at 8.320, market cap of 3.3 billion - Aidi Kang Holdings: 6.81% increase, current price at 5.020, market cap of 3.7 billion - MicroPort Robotics-B: 6.49% increase, current price at 26.900, market cap of 27.7 billion [1]. Group 2: ETF Launch and Characteristics - The newly launched Hong Kong Stock Connect Healthcare ETF (159137) is designed to passively track the healthcare theme index, which includes key sectors such as CXO, AI healthcare, medical devices, and innovative drugs [3]. - The healthcare theme index has demonstrated high elasticity and volatility, with a maximum increase of over 148% during the last healthcare bull market, significantly outperforming comparable indices [3]. Group 3: Recent Developments and Innovations - Recent advancements in brain-computer interfaces and AI healthcare have led to increased attention in the healthcare sector, with OpenAI launching ChatGPTHealth and Neuralink planning large-scale production of brain-computer interface devices by 2026 [4][5]. - Tsinghua University has developed an AI-driven high-throughput drug virtual screening platform, showcasing significant research progress in the field [5]. - The National Medical Products Administration in China is working on standards for medical devices utilizing brain-computer interface technology, indicating a supportive regulatory environment for innovation [5]. Group 4: Investment Opportunities - The A-share market offers investment tools such as the largest healthcare ETF (512170), which includes 12 AI healthcare and brain-computer interface concept stocks, with a combined weight of over 36% [6]. - The current price-to-earnings ratio of the CSI Healthcare Index is 35.46, indicating a favorable valuation compared to historical averages, suggesting potential investment opportunities [6].

1月12日，港股通医疗板块继续活跃，脑机接口、AI医疗等概念领涨，微创机器人-B涨超6%，微创脑科 学涨超4%，阿里健康涨逾2%。港股通医疗主题指数一度涨超1%，2026开年以来连续7日上涨！ | 序号 | 名称 | 现价 | 涨跌幅 ▼ | 月7:57:30 | 总市值 | | --- | --- | --- | --- | --- | --- | | 1 | 一脉阳光 | 8.320 | 8.76% | 1.33亿 | 33亿 | | 2 | 艾迪康控股 | 5.020 | 6.81% | 690.76万 | 37亿 | | 3 | 微创机器人-B | 26.900 | 6.49% | 1.25 Z | 277亿 | | ব | 医脉通 | 12.620 | 6.41% | 1.74Z | 93亿 | | 5 | 微创脑科学 | 13.090 | 4.64% | 1.15 Z | 77亿 | | 6 | 方舟健客 | 2.180 | 3.32% | 287.41万 | 29亿 | | 7 | 脑动极光-B | 7.590 | 2.99% | 1.64 Z | 96亿 | | 8 | 阿里健康 | 5.93 ...

全球AI医疗市场正迈入万亿级增长通道。据Grand View Research报告显示，2024年全球AI医疗市场规模 约为266.5亿美元（约合人民币1861亿元），预计到2033年将飙升至约5055.9亿美元（约合人民币3.5万 亿元），期间年复合增长率达38.8%。 1月12日，医渡科技(02158)开盘后股价强势拉升，涨幅一度超过9%，截至发稿，涨7.45%，报6.35港 元，成交额1.49亿港元。 东莞证券表示，随着国内科技巨头积极布局AI医疗赛道，有望快速推进我国医疗信息化和普惠化进 程，并加速AI垂类应用场景落地，医疗或成为AI垂类应用场景的重要突破口。 消息面上，近日，由北京大学第一医院牵头，医渡科技参与共建的"多模态智能诊疗系统研发与转化应 用北京市重点实验室"成功获批。该实验室将聚焦心肾代谢综合征的智能化诊疗攻关，是医渡科技持续 深耕专科智能诊疗的又一个关键里程碑。作为实验室的核心共建方，医渡科技将大模型技术能力，深度 注入实验室的研发链条，为智能诊疗的落地提供坚实底座。 ...